Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

NCT00358436 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00358436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00358436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
June 30, 2008
Enrollment
804 (actual)
Sites
120

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)